Gentian Diagnostics ASA (OSL: GENT)
Norway
· Delayed Price · Currency is NOK
41.00
-0.20 (-0.49%)
Nov 21, 2024, 4:25 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 635.40 million as of November 21, 2024. Its market cap has increased by 3.00% in one year.
Market Cap
635.40M
Enterprise Value
548.22M
Revenue
154.12M
Ranking
n/a
PE Ratio
286.21
Stock Price
41.00
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 635.40M, an increase of 119.39%. That is a compound annual growth rate of 10.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nordhealth AS | 2.96B |
Medistim ASA | 2.42B |
Carasent ASA | 1.45B |
Photocure ASA | 1.37B |
Nykode Therapeutics AS | 819.63M |
ArcticZymes Technologies ASA | 676.19M |
Hofseth BioCare ASA | 554.96M |
Thor Medical ASA | 504.95M |